Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
06/1998
06/11/1998CA2277580A1 Human chemokine beta-13
06/11/1998CA2274249A1 Inhibitors of interleukin-1.beta. converting enzyme
06/11/1998CA2274105A1 Transgenic non-human animals capable of producing heterologous antibodies
06/11/1998CA2274048A1 Pyrazoles as human non-pancreatic secretory phospholipase a2 inhibitors
06/11/1998CA2273845A1 Secreted proteins and polynucleotides encoding them
06/11/1998CA2245699A1 Substituted sulfonic acid n-¬(aminoiminomethyl)phenylalkyl}-azaheterocyclamide compounds
06/11/1998CA2224334A1 Self-enhancing, pharmacologically controllable expression systems
06/10/1998EP0846688A1 New imidazoline derivatives having affinity for the imidazoline receptor
06/10/1998EP0846687A1 Pyrazoles as human non-pancreatic secretory phospholipase A2 inhibitors
06/10/1998EP0846464A2 Use of glycogen phosphorylase inhibitor for reducing non-cardiac tissue damage resulting from ischemia
06/10/1998EP0846125A2 INHIBITORS OF FACTOR Xa
06/10/1998EP0846120A1 Low molecular weight bicyclic-area type thrombin inhibitors
06/10/1998EP0846116A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
06/10/1998EP0846115A1 New cyclic guanidines, process for preparing the same and medicaments
06/10/1998EP0845984A1 Use of aminoadamantane compounds as immunoregulators
06/10/1998EP0831817A4 Antigen-processing cell-targeted conjugates
06/10/1998CN1184483A Fucopeptides
06/10/1998CN1184428A Pharmaceutical composition containing selected lanthanum carbonate hydrates
06/10/1998CN1183987A Gynaecologist's hemostatic
06/10/1998CN1183982A Preparation of Chinese medicine for cerebral thrombus
06/09/1998US5763614 1,4-dihydropyridine derivatives and methods of producing the same
06/09/1998US5763604 Anticoagulants
06/09/1998US5763567 Human amino acid sequences which can bind to and/or neutralize heparin
06/09/1998US5763489 Naphthalene derivatives as prostaglandin I2 agonsists
06/09/1998US5763436 Guanidine derivatives
06/09/1998US5763420 Method for modulating the immune system
06/09/1998US5763411 Solid support coated with fibrin monomer readily capable of being converted to fibrin polymer sealant or hemostat
06/09/1998US5763410 Kit for preparing a fibrin sealant
06/09/1998US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus
06/09/1998US5763211 Polynucleotide which encodes receptor polypeptide
06/09/1998US5763195 Method and compositions for making ACSF and ACSF antagonists
06/09/1998US5762922 Antioxidants and intracellular gluthathione raising agents for therapeutic treatments
06/09/1998US5762920 Megakaryocyte production
06/09/1998CA2148078C Platelet aggregation inhibitor
06/05/1998CA2223317A1 Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
06/04/1998WO1998023643A1 Multimeric erythropoietin with increased biological activity
06/04/1998WO1998023619A1 Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
06/04/1998WO1998023608A1 Novel integrin receptor antagonists
06/04/1998WO1998023565A2 Aminoguanidines and alkoxyguanidines as protease inhibitors
06/04/1998WO1998023279A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
06/04/1998WO1998009948A3 Nitric ester derivatives and their use in urinary incontinence and other diseases
06/04/1998WO1998000171A3 Conjugates of thrombin inhibitors and endogenes carriers
06/04/1998CA2272603A1 Multimeric erythropoietin with increased biological activity
06/04/1998CA2272565A1 Integrin receptor antagonists
06/04/1998CA2223541A1 New imidazoline derivatives, preparation process and the pharmaceutical compositions containing them
06/03/1998CN1183805A Chemokine receptos 88-2B £CKR-3| and 88C and their antibodies
06/03/1998CN1183770A Piperazine derivs, medicaments contg. same, their use and process for preparing same
06/03/1998CN1183718A Pharmacological use of certain cystine derivs.
06/03/1998CN1038585C Process for preparation of 2, 4 - and 2, 5 -substd. pyridine -N -oxides
06/02/1998US5760235 Anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for preparation thereof
06/02/1998US5760073 Treatment of central nervous system disorders
06/02/1998US5760061 Using a benzothiophene compound
06/02/1998US5760057 Anticoagulants
06/02/1998US5760012 Genetic engineered nucleotide for treating genetic disorders
06/02/1998US5760003 Hemoregulatory peptides
06/02/1998US5759994 Antithrombin peptide for cardiovascular disorders
06/02/1998US5759533 Neutrophil-activating peptide-2
06/02/1998CA2012278C Mutant of microbacterium, a strain 851r, and a process for producing 851r nutrient solution by application of the strain
05/1998
05/28/1998WO1998022606A1 Recombinant bicistron adenovirus for treating pathological conditions linked with dyslipoproteinemia
05/28/1998WO1998022583A1 IDENTIFICATION OF Bap-1, A PROTEIN THAT BINDS TO INTEGRIN AND IS INVOLVED IN INTEGRIN-MEDIATED SIGNAL TRANSDUCTION
05/28/1998WO1998022501A2 Secreted proteins and polynucleotides encoding them
05/28/1998WO1998022500A2 Modulation of interactions between myosin and integrins
05/28/1998WO1998022483A1 New phosphonates, process for preparing the same and medicaments
05/28/1998WO1998022460A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998WO1998022443A1 N-(imidazolylbutyl) benzenesulphonamide derivatives, their preparation and therapeutic application
05/28/1998WO1998022436A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
05/28/1998WO1998022426A1 New manufacturing process of metoprolol
05/28/1998WO1998022125A1 Peptidomimetics containing 6-peptidylamino-1-naphthalenesulfonamide moieties
05/28/1998WO1998021957A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998DE19649460A1 Neue substituierte Pyrazolderivate New substituted pyrazole derivatives
05/28/1998CA2272095A1 Peptidomimetics containing 6-peptidylamino-1-naphthalenesulfonamide moieties
05/28/1998CA2272050A1 Secreted proteins and polynucleotides encoding them
05/28/1998CA2271963A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998CA2271954A1 Identification of bap-1, a protein that binds to integrin and is involved in integrin-mediated signal transduction
05/28/1998CA2271814A1 New phosphonates, process for preparing the same and medicaments
05/28/1998CA2271437A1 Recombinant bicistron adenovirus for treating pathological conditions linked with dyslipoproteinemia
05/28/1998CA2270478A1 N-(imidazolylbutyl) benzenesulphonamide derivatives, their preparation and therapeutic application
05/28/1998CA2269941A1 New manufacturing process of metoprolol
05/28/1998CA2268770A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
05/28/1998CA2268037A1 Bicyclic aryl carboxamides and their therapeutic use
05/27/1998EP0844000A1 Use of alpha, omega-diarylalkane derivatives in the treatment and prevention of psychosis
05/27/1998EP0843671A1 Heterocyclic compounds and pharmaceutical compositions containing them
05/27/1998EP0843549A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4? hydrolase inhibitor
05/27/1998EP0656889B1 9-chloroprostaglandin esters and amides and their use in the preparation of drugs
05/27/1998CN1183120A Low oxygen affinity mutant hemoglobin
05/27/1998CN1038505C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
05/26/1998US5756668 Hypermethylated in cancer polypeptide, HIC-1
05/26/1998US5756519 Fibrinogen receptor antagonists
05/26/1998US5756504 Tocolytic oxytocin receptor antagonists
05/26/1998US5756499 Substituted imidazole compounds
05/26/1998US5756464 Therapeutic uses of BPI protein products in humans with hemmorhage due to trauma
05/26/1998US5756452 Cyclic polypeptide
05/26/1998US5756349 Culture of cells and radioimmunoassay
05/26/1998US5756084 Human stromal derived factor 1α and 1β
05/26/1998US5755237 Intravenous injection
05/26/1998CA2052073C Sulfonamide fibrinogen receptor antagonists
05/22/1998WO1998021332A2 Secreted proteins and polynucleotides encoding them
05/22/1998WO1998021193A1 Antithrombotic organic nitrates
05/22/1998WO1998021188A1 HETEROCYCLE DERIVATIVES WHICH INHIBIT FACTOR Xa
05/22/1998WO1998021177A1 Benzenesulfonamide derivatives and drugs containing the same
1 ... 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 ... 671